Cite
New Aspergillosis Study Findings Recently Were Reported by Researchers at Hebrew University of Jerusalem (Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis In High-risk Hemato-oncology Patients)
MLA
“New Aspergillosis Study Findings Recently Were Reported by Researchers at Hebrew University of Jerusalem (Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis In High-Risk Hemato-Oncology Patients).” TB & Outbreaks Week, 18 July 2023, p. 415. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.757311023&authtype=sso&custid=ns315887.
APA
New Aspergillosis Study Findings Recently Were Reported by Researchers at Hebrew University of Jerusalem (Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis In High-risk Hemato-oncology Patients). (2023, July 18). TB & Outbreaks Week, 415.
Chicago
TB & Outbreaks Week. 2023. “New Aspergillosis Study Findings Recently Were Reported by Researchers at Hebrew University of Jerusalem (Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis In High-Risk Hemato-Oncology Patients),” July 18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.757311023&authtype=sso&custid=ns315887.